Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference
May 06, 2021 07:00 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging...
Finch Therapeutics Appoints Susan E. Graf to Board of Directors
April 27, 2021 07:00 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging...
Finch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics Summit
April 15, 2021 07:00 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging...
Finch Therapeutics Announces Pricing of Upsized Initial Public Offering
March 18, 2021 22:32 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its...